Noticias de NVCR_US

Noticias del mercado

Últimas noticias sobre NVCR_US — 55 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: NVCR_US ✕ 55 resultados
27/03/2026 NVCR_US — Minichart
NovoCure Limited Files 8-K Report Detailing Tumor Treating Fields Therapy and Corporate Information March 2026
26/03/2026 NVCR_US — Stocktwits
NVCR Stock Gains After Novocure Announces Positive Topline Results In Metastatic Pancreatic Cancer Therapy Trial
26/03/2026 NVCR_US — Seeking Alpha
Novocure posts trial win for TTFields in pancreatic cancer
26/03/2026 NVCR_US — Stock Titan
Novocure (NASDAQ: NVCR) reports positive PANOVA-4 pancreatic cancer data
18/03/2026 NVCR_US — MSN ES ← EN
Novocure obtiene la aprobación de la FDA para Optune Pax para tratar el cáncer de páncreas
09/03/2026 NVCR_US — Yahoo Finance
Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment
02/03/2026 NVCR_US — Seeking Alpha
NovoCure Limited 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:NVCR) 2026-03-02
02/03/2026 NVCR_US — Yahoo Finance
NovoCure (NVCR) Reliance on International Sales: What Investors Need to Know
26/02/2026 NVCR_US — marketscreener.com
NovoCure's Q4 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Issued
26/02/2026 NVCR_US — Stock Traders Daily
(NVCR) and the Role of Price-Sensitive Allocations
26/02/2026 NVCR_US — Yahoo Finance
NovoCure Limited Q4 2025 Earnings Call Summary
26/02/2026 NVCR_US — Yahoo Finance ES ← EN
NovoCure (NVCR) informa pérdidas en el cuarto trimestre y supera las estimaciones de ingresos
25/02/2026 NVCR_US — MSN
NovoCure Q4 2025 earnings preview
24/02/2026 NVCR_US — marketscreener.com ES ← EN
Novocure Ltd dice que CMS restablece los privilegios de facturación de Medicare de forma retroactiva: presentación ante la SEC
24/02/2026 NVCR_US — DirectorsTalk Interviews
NovoCure Limited (NVCR) Investor Outlook: Exploring A Potential 129.64% Upside
19/02/2026 NVCR_US — Yahoo Finance ES ← EN
¿NovoCure (NVCR) informará ganancias negativas la próxima semana? Lo que debes saber
17/02/2026 NVCR_US — DirectorsTalk Interviews
NovoCure Limited (NVCR) Stock Analysis: Unveiling a 129% Upside Potential in the Tumor Treating Fields Market
17/02/2026 NVCR_US — Yahoo Finance
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
15/02/2026 NVCR_US — Stock Traders Daily
Responsive Playbooks and the NVCR Inflection
13/02/2026 NVCR_US — CoinCentral
NovoCure (NVCR) Stock Soars Following Pancreatic Cancer Treatment Approval

Página 2 de 3

keyboard_arrow_up